Members of the Lobular Breast Cancer Alliance community, I am Bob McDevitt, Chair of the LBCA Board of Directors, writing on behalf of the Board […]
Exciting Opportunity to Explore a Role on the LBCA Board of Directors Read More »
Participation in clinical trials is one way that patients who are affected by ILC can help advance the understanding of lobular breast disease. These are
New ILC Clinical Trials Now Open Read More »
The Lobular Breast Cancer Alliance and Susan G. Komen are excited to announce the grant recipients of the Susan G. Komen-Lobular Breast Cancer Alliance Metastatic
LBCA Patient Advocates Jade Moran and Janice Axelrod recently interviewed LBCA’s 2 newest Scientific Advisory Board Members Jade Moran interviewed new SAB Member Dr. Pooja Advani,
METAvivor, in partnership with LBCA is launching a new virtual peer-to-peer support group specifically for individuals living with Stage IV metastatic invasive lobular carcinoma (mILC).
New Metastatic ILC Support Group through Metavivor and LBCA Read More »
LBCA invites you this first session of a four part series on liquid biopsy/CtDNA tests and relevance for ILC. In this first session, clinician/researchers Drs.
Liquid Biopsy Webinar Series: Overview of Liquid Biopsy Testing and Relevance for ILC Read More »
LBCA is pleased to announce that through a new collaboration between LBCA and Breast Cancer Research Foundation (BCRF) and through AACR, which has helped LBCA
LBCA, BCRF and AACR fund ILC Career Development ILC Research Grant Solicitation Read More »
In honor of the 15% of breast cancer diagnoses that are lobular, we’ve set a goal to raise $150K for more ILC research during Breast
October 15th is 2 months away! The 2nd annual Global Lobular Breast Cancer Awareness Day is coming up soon and we’re hard at work planning
Get Involved to Help Spread the Word about Lobular Breast Cancer We’re three months away from lobular breast cancer’s important day during Breast Cancer Awareness
The 2nd Annual Global Lobular Breast Cancer Awareness Day is Oct. 15th! Read More »
LBCA Executive Director, Laurie Hutcheson recently interviewed our newest Scientific Advisory Board (SAB) member, Dr. Anita Mamtani, to talk about her work in breast cancer
LBCA is proud to announce the first of a series of ILC educational offerings for different types of clinicians.. LBCA partnered with our Scientific Advisory
"*" indicates required fields